194 related articles for article (PubMed ID: 10354022)
1. Human leucocyte antigen class II associations in chronic idiopathic urticaria.
O'Donnell BF; O'Neill CM; Francis DM; Niimi N; Barr RM; Barlow RJ; Kobza Black A; Welsh KI; Greaves MW
Br J Dermatol; 1999 May; 140(5):853-8. PubMed ID: 10354022
[TBL] [Abstract][Full Text] [Related]
2. Is there any relationship between human leucocyte antigen class II and chronic urticaria? (chronic urticaria and HLA class II).
Oztas P; Onder M; Gonen S; Oztas MO; Soylemezoglu O
Yonsei Med J; 2004 Jun; 45(3):392-5. PubMed ID: 15227724
[TBL] [Abstract][Full Text] [Related]
3. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients.
Hodak E; Lapidoth M; Kohn K; David D; Brautbar B; Kfir K; Narinski N; Safirman S; Maron M; Klein K
Br J Dermatol; 2001 Dec; 145(6):974-80. PubMed ID: 11899152
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
5. HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia.
Stanevicha V; Eglite J; Sochnevs A; Gardovska D; Zavadska D; Shantere R
Arthritis Res Ther; 2003; 5(6):R340-6. PubMed ID: 14680508
[TBL] [Abstract][Full Text] [Related]
6. HLA class II alleles influence rheumatoid arthritis susceptibility and autoantibody status in South Indian Tamil population.
Mariaselvam CM; Fortier C; Charron D; Krishnamoorthy R; Tamouza R; Negi VS
HLA; 2016 Nov; 88(5):253-258. PubMed ID: 27753285
[TBL] [Abstract][Full Text] [Related]
7. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity.
Huang W; Connor E; Rosa TD; Muir A; Schatz D; Silverstein J; Crockett S; She JX; Maclaren NK
J Clin Endocrinol Metab; 1996 Jul; 81(7):2559-63. PubMed ID: 8675578
[TBL] [Abstract][Full Text] [Related]
8. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
9. Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds.
Maciel LM; Rodrigues SS; Dibbern RS; Navarro PA; Donadi EA
Thyroid; 2001 Jan; 11(1):31-5. PubMed ID: 11272094
[TBL] [Abstract][Full Text] [Related]
10. Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7.
Morse JH; Barst RJ; Fotino M; Zhang Y; Flaster E; Gharavi AE; Fritzler MJ; Dominguez M; Angles-Cano E
Am J Respir Crit Care Med; 1997 Jan; 155(1):274-8. PubMed ID: 9001324
[TBL] [Abstract][Full Text] [Related]
11. Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production.
Setterfield J; Theron J; Vaughan RW; Welsh KI; Mallon E; Wojnarowska F; Challacombe SJ; Black MM
Br J Dermatol; 2001 Sep; 145(3):406-14. PubMed ID: 11531829
[TBL] [Abstract][Full Text] [Related]
12. Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis.
Tuokko J; Reijonen H; Ilonen J; Anttila K; Nikkari S; Möttönen T; Yli-Kerttula U; Toivanen A
Ann Rheum Dis; 1997 Jan; 56(1):37-40. PubMed ID: 9059139
[TBL] [Abstract][Full Text] [Related]
13. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2.
Bittencourt PL; Goldberg AC; Cançado EL; Porta G; Carrilho FJ; Farias AQ; Palacios SA; Chiarella JM; Abrantes-Lemos CP; Baggio VL; Laudanna AA; Kalil J
Am J Gastroenterol; 1999 Jul; 94(7):1906-13. PubMed ID: 10406258
[TBL] [Abstract][Full Text] [Related]
14. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity.
Sabroe RA; Fiebiger E; Francis DM; Maurer D; Seed PT; Grattan CE; Black AK; Stingl G; Greaves MW; Barr RM
J Allergy Clin Immunol; 2002 Sep; 110(3):492-9. PubMed ID: 12209101
[TBL] [Abstract][Full Text] [Related]
15. Multiple basal cell carcinomas: no association with HLA-DRB, HLA-DQA1 or HLA-DQB1 in Swedish patients.
Emtestam L; Wallberg P; Aldener A; Olerup O
Br J Dermatol; 1996 May; 134(5):886-91. PubMed ID: 8736330
[TBL] [Abstract][Full Text] [Related]
16. Differential immunogenetic determinants of polyclonal insulin autoimmune syndrome (Hirata's disease) and monoclonal insulin autoimmune syndrome.
Uchigata Y; Tokunaga K; Nepom G; Bannai M; Kuwata S; Dozio N; Benson EA; Ronningen KS; Spinas GA; Tadokoro K
Diabetes; 1995 Oct; 44(10):1227-32. PubMed ID: 7556962
[TBL] [Abstract][Full Text] [Related]
17. Analysis of HLA class II polymorphism using polymerase chain reaction.
Erlich H; Bugawan T; Begovich A; Scharf S
Arch Pathol Lab Med; 1993 May; 117(5):482-5. PubMed ID: 8489336
[TBL] [Abstract][Full Text] [Related]
18. HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset.
Fain PR; Babu SR; Bennett DC; Spritz RA
Pigment Cell Res; 2006 Feb; 19(1):51-7. PubMed ID: 16420246
[TBL] [Abstract][Full Text] [Related]
19. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity to bee venom antigen phospholipase A2: association with specific HLA class I and class II alleles and haplotypes in beekeepers and allergic patients.
Sánchez-Velasco P; Antón E; Muñoz D; Martínez-Quesada J; Ruíz de Alegría C; López-Hoyos M; García-Martín A; Jiménez I; Alonso ST; Duque S; Suárez A; Jerez J; Leyva-Cobián F
Hum Immunol; 2005 Jul; 66(7):818-25. PubMed ID: 16112029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
